About

Shanivi Srikonda

Harvard alum, scientist, writer

shaniviheadshot.jpg

Harvard '24

Boston, MA

Hi, I’m Shanivi! I’m currently a research associate at Dana-Farber Cancer Institue, interested in cancer genetics and immunology. In May 2024, I graduated from Harvard College with an A.B. in Human Developmental and Regenerative Biology, high honors.

I like exploring why and how things work in the spheres of science + medicine, and I’m planning to pursue a career that combines both research and patient care. I’m interested in oncology, and I’m particularly motivated by the following questions:

  • In the context of rare cancers, such as tRCC, how can we leverage the genetic vulnerabilities and hallmarks of cancer to develop more effective therapies?
  • How can we improve responses to cancer immunotherapy, and patient outcomes?
  • What role does the immune system play in regulating cancer progression, specifically in terms of antigen detection and presentation?
  • How do we better serve patients with serious cancer diagnoses, especially in terms of serious illness conversations (SIC)?
  • How can we more effectively incorporate patients’ unique identities in the way we deliver robust care?

Selected Publications

2024

  1. TO
    Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer
    Tejaswini M Dhawale, Roopa S Bhat, P Connor Johnson, Shanivi Srikonda, and 7 more authors
    The Oncologist, Aug 2024

2023

  1. JCO
    Using telehealth to conduct serious illness conversations (SIC) for patients with metastatic lung cancer during the COVID-19 pandemic.
    TM Dhawale, RS Bhat, PC Johnson, S Srikonda, and 7 more authors
    Journal of Clinical Oncology, 2023 ASCO Annual Conference, Abstract e13687, Jun 2023